Theragnostics was incorporated in the UK in 2015 with the aim of providing a portfolio of products to transform patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.

The word Theragnostics is derived from Therapy and Diagnostics, and refers to the strategy of utilising radioactively labelled drugs. The allows us to image distribution with one radioactive isotope for diagnostic and treatment planning purposes prior to treatment of disease by a change of radioactive isotope to an appropriate therapeutic option. Unlike conventional external beam radiotherapy the “Theragnostic” approach provides molecularly targeted delivery of radiation to cancer cells.

Theragnostics currently has offices in London, UK and Boston, USA and a clinical stage pipeline of agents addressing unmet clinical needs in several cancers.

Board of Directors Management Team Advisory Board

Theragnostics was incorporated in the UK in 2015 with the aim of providing a portfolio of products to transform patient care in oncology through targeted molecular radiotherapy and molecular imaging diagnostic products.

The word Theragnostics is derived from Therapy and Diagnostics, and refers to the strategy of utilising radioactively labelled drugs. The allows us to image distribution with one radioactive isotope for diagnostic and treatment planning purposes prior to treatment of disease by a change of radioactive isotope to an appropriate therapeutic option. Unlike conventional external beam radiotherapy the “Theragnostic” approach provides molecularly targeted delivery of radiation to cancer cells.

Theragnostics currently has offices in London, UK and Boston, USA and a clinical stage pipeline of agents addressing unmet clinical needs in several cancers.

Board of Directors Management Team Advisory Board

MISSION

To drive innovation in
the fight against cancer.
Enhancing patients’ lives with precision
radiopharmaceuticals for personalized medicine.

VISION

To develop a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring.

LEARN MORE

MISSION

    VISION

To drive innovation in the fight against cancer. Enhancing patients’ lives with precision radiopharmaceuticals for
personalized medicine.

To develop a complete portfolio of products to transform patient care, from initial diagnosis to therapy, including treatment planning and monitoring.